COMPELLING SCIENCE the study showed that Adva-27a
Post# of 212
Posted On: 11/06/2012 7:03:00 PM
Re: retireearly #16
COMPELLING SCIENCE
the study showed that Adva-27a is significantly more effective at killing Multidrug Resistant Small Cell Lung Cancer cells than Etoposide, the current commonly used drug for this type of cancer. This is the second form of Multidrug Resistant Cancer that Adva-27a has shown effectiveness against. The first, which we had announced on July 11, 2011, was MCF-7/MDR Multidrug Resistant Breast Cancer.
(0)
(0)